Titan Pharmaceuticals, Inc. (TTNP)

Titan Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.8	2.83	6.76	2.94	6.04	5.41
Cash & Short-Term Investments	2.8	2.83	6.76	2.94	6.04	5.41
Cash Growth	-31.50%	-58.12%	130.17%	-51.35%	11.53%	3.64%
Accounts Receivable	-	-	0.05	0.04	0.11	0.88
Other Receivables	0.14	0.06	1	-	-	-
Total Trade Receivables	0.14	0.06	1.05	0.04	0.11	0.88
Inventory	-	-	-	0.11	0.29	0.33
Other Current Assets	0.11	0.03	0.21	0.52	0.79	0.7
Total Current Assets	3.05	2.92	8.02	3.6	7.23	7.33
Net Property, Plant & Equipment	-	-	0.07	0.41	0.72	0.76
Other Long-Term Assets	-	-	-	0.05	0.05	-
Total Assets	3.05	2.92	8.09	4.06	7.99	8.09

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	0.22	0.2	0.35	0.7	0.8	1.25
Accrued Expenses	0.04	0.28	0.52	1.49	0.32	0.53
Short-Term Debt	-	-	0.5	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.33
Current Portion of Leases	-	-	0.07	0.12	0.11	0.15
Unearned Revenue	-	-	0.01	0.2	0.3	-
Other Current Liabilities	-	-	-	0.13	1.14	1.96
Total Current Liabilities	0.26	0.48	1.44	2.63	2.67	4.22
Long-Term Debt	-	-	-	-	-	0.33
Long-Term Leases	-	-	-	0.07	0.19	-
Total Long-Term Liabilities	-	-	-	0.07	0.19	0.33
Total Liabilities	0.26	0.48	1.44	2.7	2.86	4.56

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Preferred Stock	0	0	0	-	-	-
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-in Capital	400.57	398.97	398.47	387.62	381.18	370.8
Retained Earnings	-397.79	-396.54	-391.83	-386.26	-376.06	-367.28
Shareholders' Equity	2.79	2.44	6.64	1.36	5.14	3.53
Total Liabilities & Equity	3.05	2.92	8.09	4.06	7.99	8.09

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	-	0	0.57	0.19	0.3	0.81
Net Cash (Debt)	2.8	2.83	6.2	2.75	5.74	4.6
Net Cash Growth	-31.50%	-54.30%	125.27%	-52.07%	24.63%	488.75%
Net Cash Per Share	2.91	3.15	8.24	4.09	11.79	24.41
Book Value	2.79	2.44	6.64	1.36	5.14	3.53
Book Value Per Share	2.89	2.71	8.83	2.03	10.56	18.72
Tangible Book Value	2.79	2.44	6.64	1.36	5.14	3.53
Tangible Book Value Per Share	2.89	2.71	8.83	2.03	10.56	18.72

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jun 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error